China Regenerative Medicine International Ltd. (8158)

Overview

China Regenerative Medicine International Limited operates as an investment holding company primarily in Hong Kong and the People's Republic of China. It specializes in the production and sale of healthcare products and services, focusing on the development of treatments and solutions that encourage the body's natural regenerative processes. The enterprise has undergone significant transformations since its establishment in 1995, including a name change from China Bio-Med Regeneration Technology Limited to its current designation in March 2015. With its headquarters situated in Tsim Sha Tsui, Hong Kong, the company continues to pioneer in the field of regenerative medicine, promoting health and wellness across varied demographics.

Products and Services

China Regenerative Medicine International Limited offers a comprehensive suite of healthcare products and services tailored to enhance overall well-being and address specific health issues. Their offerings include:

• Health Management Services: Catering to individual health needs, these services offer a thorough assessment of the patient's health situation, followed by treatments focused on detoxification, balancing the inner body, nourishment of organs, and boosting the immune system. The goal is to holistically improve health and prevent disease.
• Beauty Services: Aiming at both aesthetic enhancement and skin health, their beauty services span from non-surgical medical aesthetic treatments to basic skincare. Offerings also extend to solutions for maintaining youthful skin, hair revitalization, lines firming, and partial remodeling. Furthermore, intimate rejuvenation treatment services are available, which showcase the company’s commitment to comprehensive wellness and beauty care.